Published in J Clin Oncol on March 05, 2012
Classification of current anticancer immunotherapies. Oncotarget (2014) 1.55
Trial Watch: Immunostimulatory cytokines. Oncoimmunology (2013) 0.96
Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology (2014) 0.95
Macrophages support splenic erythropoiesis in 4T1 tumor-bearing mice. PLoS One (2015) 0.78
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma. Pharmacoeconomics (2016) 0.77
Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology (2015) 0.77
Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis. J Natl Cancer Inst (2013) 0.76
Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494). Leuk Lymphoma (2016) 0.75
Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer. Front Pharmacol (2017) 0.75
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol (2006) 8.53
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood (2004) 4.05
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol (2008) 3.49
A systematic review of the effects of resident duty hour restrictions in surgery: impact on resident wellness, training, and patient outcomes. Ann Surg (2014) 3.48
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology (2008) 3.47
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst (2005) 3.26
Medication reconciliation at hospital discharge: evaluating discrepancies. Ann Pharmacother (2008) 2.57
End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst (2011) 2.14
Impact of androgen deprivation therapy on weight gain differs by age in men with nonmetastatic prostate cancer. J Urol (2012) 2.13
The half-cycle correction revisited: redemption of a kludge. Med Decis Making (2013) 2.11
Information needs of men on androgen deprivation therapy. BJU Int (2011) 2.02
Modelling mitigation strategies for pandemic (H1N1) 2009. CMAJ (2009) 2.01
Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. J Gen Intern Med (2004) 1.81
Is there an optimal comorbidity index for prostate cancer? Cancer (2008) 1.80
The effect of English language proficiency on length of stay and in-hospital mortality. J Gen Intern Med (2004) 1.80
Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol (2011) 1.75
Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. J Urol (2009) 1.71
Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol (2003) 1.70
Ethical issues in end-of-life geriatric care: the approach of three monotheistic religions-Judaism, Catholicism, and Islam. J Am Geriatr Soc (2003) 1.65
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63
Healthcare costs associated with prostate cancer: estimates from a population-based study. BJU Int (2009) 1.62
Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection. Ann Intern Med (2007) 1.53
Optimal management of high-risk T1G3 bladder cancer: a decision analysis. PLoS Med (2007) 1.53
Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival. BJU Int (2012) 1.50
Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer. Cancer (2009) 1.50
Physical activity and quality of life after radical prostatectomy. Can Urol Assoc J (2010) 1.44
Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis. Leuk Lymphoma (2014) 1.43
Systematic review, critical appraisal, and analysis of the quality of economic evaluations in stroke imaging. Stroke (2014) 1.39
eLearning among Canadian anesthesia residents: a survey of podcast use and content needs. BMC Med Educ (2013) 1.36
The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer. Urology (2002) 1.32
Is there age bias in the treatment of localized prostate carcinoma? Cancer (2004) 1.29
Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology (2010) 1.25
Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation. J Exp Med (2002) 1.24
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2011) 1.20
Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. Can J Urol (2003) 1.17
Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection. J Gastroenterol Hepatol (2012) 1.13
Kidney transplantation in the elderly: a decision analysis. J Am Soc Nephrol (2003) 1.13
A Canadian national survey of attitudes and knowledge regarding preventive vaccines. J Immune Based Ther Vaccines (2003) 1.11
Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. Am J Gastroenterol (2009) 1.10
How well do guidelines incorporate evidence on patient preferences? J Gen Intern Med (2009) 1.08
Recognition and labeling of delirium symptoms by intensivists: does it matter? Intensive Care Med (2007) 1.04
A review and meta-analysis of prostate cancer utilities. Med Decis Making (2007) 1.03
Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer. Pediatrics (2011) 1.03
Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009. PLoS One (2012) 1.02
Changes in health utilities and health-related quality of life over 12 months following radical prostatectomy. Can Urol Assoc J (2009) 1.01
Effect of 12 months of whole-body vibration therapy on bone density and structure in postmenopausal women: a randomized trial. Ann Intern Med (2011) 1.01
Continued undertreatment of older men with localized prostate cancer. Urology (2003) 0.99
A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma. Cancer Treat Rev (2008) 0.98
Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use? BJU Int (2011) 0.98
Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol (2012) 0.98
NK4 antagonizes Tbx1/10 to promote cardiac versus pharyngeal muscle fate in the ascidian second heart field. PLoS Biol (2013) 0.92
Predictors of early mortality after radical nephrectomy with renal vein or inferior vena cava thrombectomy - a population-based study. BJU Int (2012) 0.89
The effect of nerve-sparing surgery on patient-reported continence post-radical prostatectomy. Can Urol Assoc J (2009) 0.89
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer. BJU Int (2008) 0.88
Factors associated with the high cost of liver transplantation in adults. Can J Surg (2002) 0.88
Why resident duty hours regulations must address attending physicians' workload. Acad Med (2013) 0.88
The effect of age on the morbidity of kidney surgery. J Urol (2011) 0.88
Health status utilities and the impact of pressure ulcers in long-term care residents in Ontario. Qual Life Res (2009) 0.88
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Semin Oncol (2002) 0.87
Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines. Clin Cancer Res (2003) 0.87
What is the best treatment strategy for incidentally detected small renal masses? A decision analysis. BJU Int (2011) 0.86
Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. BJU Int (2013) 0.86
The effect of meeting physical activity guidelines for cancer survivors on quality of life following radical prostatectomy for prostate cancer. J Cancer Surviv (2013) 0.86
Does cirrhosis affect quality of life in hepatitis C virus-infected patients? Liver Int (2009) 0.84
Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia. Leuk Res (2012) 0.84
The role of the ossific nucleus in the treatment of established hip dislocation. Clin Orthop Relat Res (2006) 0.83
A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning. Biol Blood Marrow Transplant (2011) 0.83
Health-state utilities in a prisoner population: a cross-sectional survey. Health Qual Life Outcomes (2009) 0.83
The effectiveness of cognitive forcing strategies to decrease diagnostic error: an exploratory study. Teach Learn Med (2011) 0.83
Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol. Leuk Res (2013) 0.83
Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A. BMC Infect Dis (2006) 0.83
Treatment of constipation in older people. CMAJ (2013) 0.82
Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A (2005) 0.82
Associations between quality of life, fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemia. Support Care Cancer (2008) 0.82
Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework. Med Decis Making (2010) 0.82
Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemia. Leuk Res (2013) 0.82
Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer. Can Urol Assoc J (2011) 0.82
Survival of patients with transformed lymphoma in the rituximab era. Ann Hematol (2014) 0.81
Effect of whole-body vibration on calcaneal quantitative ultrasound measurements in postmenopausal women: a randomized controlled trial. Calcif Tissue Int (2014) 0.81
The true risk of blood transfusion after nephrectomy for renal masses: a population-based study. BJU Int (2013) 0.81
Marker states and a health state prompt provide modest improvements in the reliability and validity of the standard gamble and rating scale in prostate cancer patients. Qual Life Res (2007) 0.81
How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis. BJU Int (2011) 0.81
An unadjusted NNT was a moderately good predictor of health benefit. J Clin Epidemiol (2006) 0.81
Volume-outcome relationships in the treatment of renal tumors. J Urol (2012) 0.80
Guidelines for health technologies: specific guidance for oncology products in Canada. Value Health (2012) 0.80
Health-related quality of life following radical prostatectomy: long-term outcomes. Qual Life Res (2014) 0.80
Prehabilitation for men undergoing radical prostatectomy: a multi-centre, pilot randomized controlled trial. BMC Surg (2014) 0.80
The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review. Ann Hematol (2008) 0.80
Development, implementation, and evaluation of an Interprofessional Falls Prevention Program for older adults. J Am Geriatr Soc (2008) 0.80
A population-based study of surgeon characteristics associated with the uptake of contemporary techniques in renal surgery. Can Urol Assoc J (2013) 0.79
Techniques for estimating health care costs with censored data: an overview for the health services researcher. Clinicoecon Outcomes Res (2012) 0.79
Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study. Can Urol Assoc J (2013) 0.78
Validation of the triage risk stratification tool to identify older persons at risk for hospital admission and returning to the emergency department. J Am Geriatr Soc (2008) 0.78
Health care costs for state transition models in prostate cancer. Med Decis Making (2013) 0.78
Cardiovascular toxicity of androgen deprivation therapy: a new door opens. J Clin Oncol (2011) 0.78
Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn's disease? A Markov analysis. Dis Colon Rectum (2004) 0.78